DIP Ep 596: 2025 USMLE Step 1 Free 120 Discussion Part 11b (Q106-110, super helpful for Step 2 and 3!)

DIP Ep 596: 2025 USMLE Step 1 Free 120 Discus...

Up next

February 2026 Step 1-3 USMLE/COMLEX Classes (Starts 2/16/2026)

In this podcast, I explain exactly what you should expect to get from all my classes. I go over each class and discuss the way they are structured, specific advantages offered by each class, and my approach to covering the material. I discuss differences between the classes and m ...  Show more

DIP Ep 630: 2 High Yield Integrated Cases (Step 1-3)

In this podcast, I discuss 2 cases that encapsulate a large number of concepts frequently tested on the USMLE exams. I discuss a host of arrows, make necessary integrations, and help you understand pathophysiology every step of the way. You will almost certainly see some antecede ...  Show more

Recommended Episodes

Episode 006: Heme Path Capstone Pt. 1
The Fellow on Call: The Heme/Onc Podcast

Heme Path Capstone Pt. 1 Pearls

It’s time to put all you have learned in our Heme Path series to the test! Listen in as our guest, Dr. Emily Mason, hematopathologist at Vanderbilt University Me ...

  Show more

Episode 136: Follicular Lymphoma Series, Pt. 1 - Introduction
The Fellow on Call: The Heme/Onc Podcast

This week, we kick off a new series, this time focusing on follicular lymphoma! This series will build on a lot of fundamentals that we discussed in our prior series. In this first episode, we start with an ...

  Show more

Episode 116: AML Series, Pt. 2 - MDS/AML Diagnosis and Risk Stratification
The Fellow on Call: The Heme/Onc Podcast

In this week’s episode, we discuss the diagnostic criteria and risk stratification for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), building on our discussion from last week. Also, if you have not done so, please do check out our hemepath series to ensure y ...

  Show more

Episode 139: Follicular Lymphoma Series, Pt 4 - Relapsed/Refractory Management (Cellular therapy options)
The Fellow on Call: The Heme/Onc Podcast

This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we h ...

  Show more